CD20/MS4A1 linear peptide (WPRWLEN, 7-aa) contains motif WPXWLE, 6-aa; Rp1L-1) and reacts with rituximab
-
Catalog number
RP1L-P
-
Price
Please ask
-
Size
100 ug
-
-
Stock availability
Available
-
Category
Antibody Blocking Peptide
-
Antibody type
N/A
-
Antibody host
N/A
-
Antibody conjugate
N/A
-
Technical datasheet
Contact Gentaur to request the datasheet or ask our specialists for more information.
-
Notes
The CD20/MS4A1 linear peptide (WPRWLEN, 7-aa) contains motif WPXWLE, 6-aa; Rp1L-1) and reacts with rituximab is manufactured for Research Use Only or for diagnostics purposes.
-
-
Description
Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
-
Gene target
-
Gene symbol
MS4A1
-
Short name
CD20/MS4A1 linear peptide (WPRWLEN, 7-aa) contains motif WPXWLE, 6-aa; Rp1L-1) reacts with rituximab
-
Technique
peptide, peptides
-
Species
N/A
-
Alternative name
CD20/membrane-spanning 4-domains, subfamily A, member 1 linear short protein sequence (WPRWLEN, 7-aa) contains motif WPXWLE, 6-aa; Rp1L-1) and reacts including rituximab
-
Alternative technique
peptides
-
Alternative to gene target
membrane-spanning 4-domains, subfamily A, member 1, B1 and Bp35 and CD20 and CVID5 and LEU-16 and MS4A2 and S7, MS4A1 and IDBG-49101 and ENSG00000156738 and 931, MHC class II protein complex binding, Extracellular, Ms4a1 and IDBG-146027 and ENSMUSG00000024673 and 12482, BT.53744 and IDBG-638183 and ENSBTAG00000004580 and 505653
-
Gene info
Similar products
